MKI67 and neoplasm: In the subcutaneous xenograft model, MAP17 knockdown remarkably retarded tumor growth as demonstrated by tumor volume, tumor weight, and the expression of proliferation index Ki67 (Fig. 3b and Supplementary Figure 4).